103 related articles for article (PubMed ID: 2296341)
21. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients.
Westhuyzen J; Foreman K; Battistutta D; Saltissi D; Fleming SJ
Am J Nephrol; 1992; 12(1-2):29-36. PubMed ID: 1415362
[TBL] [Abstract][Full Text] [Related]
22. Can a different priming process of the dialyzer affect dialysis adequacy in chronic hemodialysis patients?
Dursun B; Unal S; Varan HI; Suleymanlar G
Ren Fail; 2004 Mar; 26(2):155-7. PubMed ID: 15287199
[TBL] [Abstract][Full Text] [Related]
23. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
24. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
25. Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition.
Igarashi H; Kioi S; Gejyo F; Arakawa M
Nephron; 1985; 41(1):62-9. PubMed ID: 3929152
[TBL] [Abstract][Full Text] [Related]
26. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
27. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
28. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
[TBL] [Abstract][Full Text] [Related]
29. Complement activation is influenced by the membrane material, design of the dialyser, sterilizing method, and type of dialysate.
Lundberg L; Johansson G; Karlsson L; Stegmayr BG
Nephrol Dial Transplant; 1994; 9(9):1310-4. PubMed ID: 7816297
[TBL] [Abstract][Full Text] [Related]
30. Is the dialysate fluid source of complement activating factors?
Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
[TBL] [Abstract][Full Text] [Related]
31. Impact of spacing filaments external to hollow fibers on dialysate flow distribution and dialyzer performance.
Ronco C; Scabardi M; Goldoni M; Brendolan A; Crepaldi C; La Greca G
Int J Artif Organs; 1997 May; 20(5):261-6. PubMed ID: 9209926
[TBL] [Abstract][Full Text] [Related]
32. Complement activation and hypersensitivity reactions to dialysis membranes.
Hakim RM; Breillatt J; Lazarus JM; Port FK
N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
[TBL] [Abstract][Full Text] [Related]
33. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin-induced shock in the rat. A role for C5a.
Smedegård G; Cui LX; Hugli TE
Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies.
Lemke HD; Heidland A; Schaefer RM
Nephrol Dial Transplant; 1990; 5(4):264-9. PubMed ID: 2113222
[TBL] [Abstract][Full Text] [Related]
36. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
[TBL] [Abstract][Full Text] [Related]
37. The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organs.
Oka T
ASAIO Trans; 1989; 35(4):778-83. PubMed ID: 2611046
[TBL] [Abstract][Full Text] [Related]
38. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
Marc MM; Korosec P; Kosnik M; Kern I; Flezar M; Suskovic S; Sorli J
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
[TBL] [Abstract][Full Text] [Related]
39. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
